Explore more publications!
US Healthcare Journal
Got News to Share?

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on January 11, 2026

South Country Health Alliance Selects Itiliti Health’s PA Checkpoint to Streamline Prior Authorization Transparency
Jan. 11, 2026

South Country Health Alliance Selects Itiliti Health’s PA Checkpoint to Streamline Prior Authorization Transparency

Indeterminate EIN Presswire
GenServe.AI Launches GENIE™, the First Vendor-Agnostic Orchestration and Command Center for Voice and Clinical AI Agents
Jan. 11, 2026

GenServe.AI Launches GENIE™, the First Vendor-Agnostic Orchestration and Command Center for Voice and Clinical AI Agents

Indeterminate EIN Presswire
Tampa Weight Loss Institute Celebrates One Year of Transforming Lives Through Advanced Bariatric Surgery in Tampa, FL
Jan. 11, 2026

Tampa Weight Loss Institute Celebrates One Year of Transforming Lives Through Advanced Bariatric Surgery in Tampa, FL

Indeterminate EIN Presswire
Levels of Self Launches Coaching for Armenian and Russian Speakers Worldwide
Jan. 11, 2026

Levels of Self Launches Coaching for Armenian and Russian Speakers Worldwide

Indeterminate EIN Presswire
West Medical Expands Access to Advanced Vein and Weight Loss Treatments in Southern California
Jan. 11, 2026

West Medical Expands Access to Advanced Vein and Weight Loss Treatments in Southern California

Indeterminate EIN Presswire
MicroTouch Unveils New Mach 15.6" Android POS System at NRF 2026
Jan. 11, 2026

MicroTouch Unveils New Mach 15.6" Android POS System at NRF 2026

Indeterminate EIN Presswire
MicroTouch Showcases Next-Gen Touch Solutions and Launches Android 15 Across Its Mach Line at NRF 2026
Jan. 11, 2026

MicroTouch Showcases Next-Gen Touch Solutions and Launches Android 15 Across Its Mach Line at NRF 2026

Indeterminate EIN Presswire
Zymeworks Outlines Strategic Priorities and Outlook for 2026
Jan. 11, 2026

Zymeworks Outlines Strategic Priorities and Outlook for 2026

Indeterminate GlobeNewswire
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Jan. 11, 2026

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Indeterminate GlobeNewswire
Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones
Jan. 11, 2026

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones

Indeterminate GlobeNewswire
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
Jan. 11, 2026

Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance

Indeterminate GlobeNewswire
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
Jan. 11, 2026

Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results

Indeterminate GlobeNewswire
Drs. William Ziegler & Alan Martinez Named 2025 NJ Top Docs
Jan. 11, 2026

Drs. William Ziegler & Alan Martinez Named 2025 NJ Top Docs

Indeterminate EIN Presswire
Exagen Inc. Announces Select Preliminary 2025 Financial Results
Jan. 11, 2026

Exagen Inc. Announces Select Preliminary 2025 Financial Results

Indeterminate GlobeNewswire
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
Jan. 11, 2026

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

Indeterminate GlobeNewswire
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
Jan. 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions